暂时受体潜在化物类型1:糖尿病模型中的心脏保护作用
Jiaqi Bao1,2, Zhicheng Gao1,2, Yilan Hu1,2
1The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.
Channels (Austin, Tex.)
|November 20, 2023
概括
在糖尿病模型中,激活TRPV1通道显示出对糖尿病心肌病 (DCM) 的保护作用. 这种TRPV1通道激活可能为预防和治疗糖尿病中心脏并发症提供了一个新的治疗点.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
背景情况:
- 糖尿病显著增加了心血管疾病的风险,特别是由于糖尿病心肌病 (DCM) 的心力衰竭 (HF).
- 目前以血糖控制为重点的糖尿病管理在改善糖尿病患者的心脏结构和功能的有效性有限.
- 短暂受体潜在道子家族V成员1 (TRPV1) 在心血管系统中表达,其激活可能提供心脏保护.
研究的目的:
- 审查糖尿病心脏中TRPV1通道激活的保护机制.
- 探索TRPV1作为糖尿病心肌病和相关心血管并发症的治疗点的潜力.
主要方法:
- 文献综述总结了糖尿病模型中TRPV1通道功能的现有研究.
- 对TRPV1在减轻氧化应激,改善线粒体功能和增强内皮功能方面的作用的证据分析.
- 在DCM的背景下,研究TRPV1对炎症和心脏能量代谢的影响.
主要成果:
- 在糖尿病心脏模型中,TRPV1通道激活显示出保护作用.
- 激活TRPV1有助于通过减少氧化/化应激和炎症来抑制DCM的进展.
- 在糖尿病心脏中,TRPV1在改善线粒体功能,内皮功能和心脏能量代谢方面发挥作用.
结论:
- TRPV1通道激活在糖尿病诱导的心肌病症中提供显著的心脏保护.
- 向TRPV1为预防和治疗与糖尿病相关的心血管并发症提供了一个有希望的治疗策略.
相关概念视频
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...